Phenesterin

    WARNING: This product is for research use only, not for human or veterinary use.

Hodoodo CAT#: H535228

CAS#: 3546-10-9

Description: Phenesterin is an alkylating agent.


Chemical Structure

img
Phenesterin
CAS# 3546-10-9

Theoretical Analysis

Hodoodo Cat#: H535228
Name: Phenesterin
CAS#: 3546-10-9
Chemical Formula: C39H59Cl2NO2
Exact Mass: 643.39
Molecular Weight: 644.806
Elemental Analysis: C, 72.65; H, 9.22; Cl, 11.00; N, 2.17; O, 4.96

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Phenesterin

IUPAC/Chemical Name: Cholest-5-en-3-ol (3beta)-, 4-(bis(2-chloroethyl)amino)benzeneacetate

InChi Key: SPJCRMJCFSJKDE-ZWBUGVOYSA-N

InChi Code: InChI=1S/C39H59Cl2NO2/c1-27(2)7-6-8-28(3)34-15-16-35-33-14-11-30-26-32(17-19-38(30,4)36(33)18-20-39(34,35)5)44-37(43)25-29-9-12-31(13-10-29)42(23-21-40)24-22-41/h9-13,27-28,32-36H,6-8,14-26H2,1-5H3/t28-,32+,33+,34-,35+,36+,38+,39-/m1/s1

SMILES Code: CC(C)CCC[C@@H](C)[C@H]1CC[C@@]2([H])[C@]3([H])CC=C4C[C@@H](OC(CC5=CC=C(N(CCCl)CCCl)C=C5)=O)CC[C@]4(C)[C@@]3([H])CC[C@]12C

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 644.81 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Bennett JM, Frank J, Sears M, Lagakos SW, Horton J, Colsky J, Hall TC. A phase II study of phenesterin (NSC-104469). Med Pediatr Oncol. 1978;4(3):241-6. doi: 10.1002/mpo.2950040307. PMID: 355820.


2: Ansfield FJ, Carter AC, Goldenberg IS, Segaloff A. Phase I study of phenesterin (NSC-104469). Cancer Chemother Rep. 1971 Jun;55(3):259-63. PMID: 5000532.


3: Bloom RE, Polivogianis L, Davis TE, Bennett JM, Horton J. Phase II evaluation of phenesterin in patients with advanced ovarian cancer. Cancer Treat Rep. 1983 Jun;67(6):601-2. PMID: 6861167.


4: National Toxicology Program. Bioassay of phenesterin for possible carcinogenicity. Natl Cancer Inst Carcinog Tech Rep Ser. 1978;60:1-146. PMID: 12830237.


5: Vollmer EP, Taylor DJ, Masnyk IJ, Cooney D, Levine B, Piczak C, Trench L. Phenesterin (NSC-104469)--clinical brochure. Cancer Chemother Rep 3. 1973 Jan;4(1):103-19. PMID: 4634116.


6: Degteva SA, Platonova GN. Vliianie asazola i fenesterina na krovetvroenie obez'ian [Effect of asazol and phenesterin on the hemopoiesis of monkeys]. Farmakol Toksikol. 1968 Jul-Aug;31(4):470-2. Russian. PMID: 4972356.


7: DEGTEVA SA. O SPEKTRE I IZBIRATEL'NOSTI PROTIVOOPUKHOLEVOGO DE ISTVIIA FENESTERINA [SPECTRUM AND SELECTIVITY OF THE ANTINEOPLASTIC AGENT PHENESTERIN]. Vopr Onkol. 1964;10:52-6. Russian. PMID: 14314135.


8: DEGTEVA SA. EXPERIMENTAL RESULTS OF NEW ANTICANCER DRUG-PHENESTERIN. Acta Unio Int Contra Cancrum. 1964;20:153-6. PMID: 14151873.


9: Schaeppi U, Heyman IA, Fleischman RW, Rosenkrantz H, Ilievski V, Phelan R, Cooney DA, Davis RD. Toxicity in beagle dogs of three alkylating esters with antitumor activity: phenesterin (NSC-104469), estradiol mustard (NSC-112259), and dehydroepiandrosterone mustard (NSC-12121). Cancer Chemother Rep 3. 1973 Jan;4(1):85-95. PMID: 4267410.


10: Degteva SA. Spectrum and selectivity of antitumor action of phenesterin. Fed Proc Transl Suppl. 1965 Nov-Dec;24(6):1111-2. PMID: 5215182.


11: Iablonovskaia LIa, Degteva SA. Deĭstvie fenesterina na glial'nye opukholi mozga mysheĭ [The effect of phenesterin on glial tumors of the mouse brain]. Arkh Patol. 1965;27(12):60-3. Russian. PMID: 5875703.


12: Feldman EB, Paul H, Cheron R. Intestinal absorption of phenesterin (NSC 104469), an alkylating cholesterol ester. Cancer Chemother Rep. 1972 Feb;56(1):1-7. PMID: 5030805.


13: Saiko AA. Vliianie fenésterina na sistemu atsetilkholin--kholinésteraza v golovnom mozgu mushei [The effect of phenesterin on the acetylcholine- cholinesterase system in the brains of mice]. Vopr Onkol. 1969;15(1):82-3. Russian. PMID: 5784523.


14: Korostin VI, Lopatin PV, Kudakova NA, Kondrat'eva TS. Issledovanie in'ektsionnykh rastvorov fenesterina, prigotovlennykh na nevodnykh rastvoriteliakh [Study of injection solutions of phenesterin prepared in nonaqueous solutions]. Farmatsiia. 1975 Jan-Feb;24(1):43-6. Russian. PMID: 1222772.


15: McGregor DB, Brown A, Cattanach P, Edwards I, McBride D, Riach C, Caspary WJ. Responses of the L5178Y tk+/tk- mouse lymphoma cell forward mutation assay: III. 72 coded chemicals. Environ Mol Mutagen. 1988;12(1):85-154. doi: 10.1002/em.2860120111. Erratum in: Environ Mol Mutagen 1988;12(3):345. PMID: 3383842.


16: Trams G, v Urban M. On the function of hormone receptors in the action of steroidal alkylating agents. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1977 Aug 15;89(3):321-30. doi: 10.1007/BF00283786. PMID: 198984.


17: Kuo EY, Esber HJ, Taylor DJ, Bogden AE. Effects of cancer chemotherapeutic agents on endocrine organs and serum levels of estrogens, progesterone, prolactin, and luteinizing hormone. Cancer Res. 1975 Aug;35(8):1975-80. PMID: 125149.


18: Wampler GL, Catsoulacos P. Antileukemic effect of homo-aza-steroidal ester of [p-[bis(2-chloroethyl)amino]phenyl]acetic acid. Cancer Treat Rep. 1977 Jan- Feb;61(1):37-41. PMID: 861962.


19: Catsoulacos P, Catsoulacos D. Antitumor activity of homo-aza-steroidal esters of p-N, N-bis(2-chloroethyl)aminophenoxyacetic acid. Anticancer Res. 1993 Jul-Aug;13(4):1203-8. PMID: 8352545.


20: LARIONOV LF, DEGTEVA SA, LESNAIA NA. [Experimental data on an antineoplastic preparation Phenestrin]. Vopr Onkol. 1962;8(4):12-4. Russian. PMID: 14462421.